What versions of Japan's Chloraniline Carbamate Tablets are there? How much do they cost?

Japanese chloroaniline carbamate tablets are a central skeletal muscle relaxant, mainly used to treat painful spasms caused by motor system disorders. The drug is developed and produced by Japan's Sawei Pharmaceutical Co., Ltd. and currently has two specifications, 125mg and 250mg. The article will introduce in detail three aspects: version classification, price information, and listing and medical insurance in the Chinese market.

What are the versions of Japanese Chloroaniline Carbamate Tablets

Japanese Chloroaniline Carbamate Tablets are divided into two main versions according to different doses and specifications to meet the treatment needs of different patients.

125mg version

The 125mg version was approved for marketing in Japan in October 1987. This version is a white round biconvex tablet with a diameter of 7.0mm, a thickness of 4.4mm, and an average weight of about 180mg. The tablet is engraved with the characteristic mark "SW 174". This strength is suitable for patients who require smaller doses or divided doses.

250mg version

The 250mg version was launched in July 1988 and was a supplement to the 125mg version. This version is a white round biconvex tablet with a diameter of 9.0mm, a thickness of 5.5mm, and an average weight of approximately 360mg. The tablet is engraved with the characteristic mark "SW 175". This specification is more suitable for patients who require larger doses or reduce the frequency of taking medications.

Two versions of Japan’s Chloraniline Carbamate Tablets provide doctors and patients with flexible treatment options that can be appropriately adjusted according to the condition and individual differences.

How much do different versions of Japanese Chloroaniline Carbamate Tablets cost?

The price of Japanese Chloroaniline Carbamate Tablets varies depending on specifications and packaging. The following is the specific price information.

Japan’s 250mg chloroaniline carbamate tablets are sold in boxes of 100 tablets for approximately US$16 per box. Due to the higher dose per tablet, patients may take fewer pills per day, making it more convenient to use.

The prices of the two specifications are similar, and patients can choose the appropriate version according to medical instructions and personal needs.

The launch and medical insurance coverage of Japan’s Chloroaniline Carbamate Tablets in China

The availability and medical insurance coverage of Japan’s Chloroaniline Carbamate Tablets in the Chinese market are the focus of many patients.

Marketing status

As of now, Japan’s chloroaniline carbamate tablets have not been officially launched in China. If patients in mainland China need to use this drug, they need to consult legal drug purchase channels through professional medical institutions, or consider other alternative treatment options.

Medical Insurance Coverage

Since this drug is not marketed in China, it has not yet been included in the Chinese Medical Insurance List. If patients need to use it, they need to purchase it entirely at their own expense. It is recommended to fully understand the indications and contraindications of the drug before purchasing and use it under the guidance of a doctor.

For Chinese patients who need treatment with this drug, it is recommended to pay close attention to its launch in the Chinese market in order to obtain legal and safe medication in a timely manner.